160 related articles for article (PubMed ID: 26313419)
1. Biomarkers and novel agents in esophago-gastric cancer: are we making progress?
Dahle-Smith A; Petty RD
Expert Rev Anticancer Ther; 2015; 15(9):1103-19. PubMed ID: 26313419
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy for advanced esophagogastric adenocarcinoma.
Kordes S; Cats A; Meijer SL; van Laarhoven HW
Crit Rev Oncol Hematol; 2014 Apr; 90(1):68-76. PubMed ID: 24183912
[TBL] [Abstract][Full Text] [Related]
3. Update on metastatic gastric and esophageal cancers.
Shah MA
J Clin Oncol; 2015 Jun; 33(16):1760-9. PubMed ID: 25918288
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer.
Ayyappan S; Prabhakar D; Sharma N
Anticancer Res; 2013 Oct; 33(10):4139-55. PubMed ID: 24122977
[TBL] [Abstract][Full Text] [Related]
5. Emerging mAbs for the treatment of esophagogastric cancer.
Ku GY; Ilson DH
Expert Opin Emerg Drugs; 2015 Mar; 20(1):63-74. PubMed ID: 25483267
[TBL] [Abstract][Full Text] [Related]
6. Current and Future Therapies for Advanced Gastric Cancer.
Davidson M; Okines AF; Starling N
Clin Colorectal Cancer; 2015 Dec; 14(4):239-50. PubMed ID: 26524924
[TBL] [Abstract][Full Text] [Related]
7. Novel targets in gastric and esophageal cancer.
Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
[TBL] [Abstract][Full Text] [Related]
8. Evolving treatments for advanced gastric cancer: appraisal of the survival trend.
Roberto M; Romiti A; Onesti CE; Zullo A; Falcone R; Marchetti P
Expert Rev Anticancer Ther; 2016 Jul; 16(7):717-29. PubMed ID: 27137418
[TBL] [Abstract][Full Text] [Related]
9. Novel targeted therapies in the treatment of gastric and esophageal cancer.
Tabernero J; Macarulla T; Ramos FJ; Baselga J
Ann Oncol; 2005 Nov; 16(11):1740-8. PubMed ID: 15980157
[TBL] [Abstract][Full Text] [Related]
10. c-Met targeting in advanced gastric cancer: An open challenge.
Marano L; Chiari R; Fabozzi A; De Vita F; Boccardi V; Roviello G; Petrioli R; Marrelli D; Roviello F; Patriti A
Cancer Lett; 2015 Aug; 365(1):30-6. PubMed ID: 26049023
[TBL] [Abstract][Full Text] [Related]
11. Systemic therapy for esophagogastric cancer: targeted therapies.
Lyons TG; Ku GY
Chin Clin Oncol; 2017 Oct; 6(5):48. PubMed ID: 29129088
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in the treatment of gastric cancer.
Ngeow J; Tan IB; Choo SP
Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
[TBL] [Abstract][Full Text] [Related]
13. Esophagogastric cancer: targeted agents.
Ku GY; Ilson DH
Cancer Treat Rev; 2010 May; 36(3):235-48. PubMed ID: 20122806
[TBL] [Abstract][Full Text] [Related]
14. Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies.
Cappetta A; Lonardi S; Pastorelli D; Bergamo F; Lombardi G; Zagonel V
Crit Rev Oncol Hematol; 2012 Jan; 81(1):38-48. PubMed ID: 21256046
[TBL] [Abstract][Full Text] [Related]
15. The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey.
Aprile G; Giampieri R; Bonotto M; Bittoni A; Ongaro E; Cardellino GG; Graziano F; Giuliani F; Fasola G; Cascinu S; Scartozzi M
Expert Opin Investig Drugs; 2014 Jul; 23(7):925-42. PubMed ID: 24806575
[TBL] [Abstract][Full Text] [Related]
16. Investigational therapies targeting the ErbB family in oesophagogastric cancer.
Moorcraft SY; Chau I
Expert Opin Investig Drugs; 2014 Oct; 23(10):1349-63. PubMed ID: 24949530
[TBL] [Abstract][Full Text] [Related]
17. Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma.
Kaur A; Dasanu CA
Expert Opin Pharmacother; 2011 Nov; 12(16):2493-503. PubMed ID: 21967344
[TBL] [Abstract][Full Text] [Related]
18. Current and Emerging Systemic Therapy in Gastro-Esophageal Cancer "The Old and New Therapy for Metastatic Disease, The Role of Adjuvant and Neoadjuvant Therapy for Localized Disease".
Lim B; Jiang Y
Curr Clin Pharmacol; 2015; 10(4):267-78. PubMed ID: 26548904
[TBL] [Abstract][Full Text] [Related]
19. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
[TBL] [Abstract][Full Text] [Related]
20. [Potentiality of Immune Checkpoint Inhibitors for Advanced Esophageal and Gastric Cancer].
Muro K
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1041-7. PubMed ID: 27628545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
